Vanguard Group’s Evolent Health EVH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $92.8M | Buy |
|
|||||
|
2025
Q2 | $123M | Sell |
|
|||||
|
2025
Q1 | $104M | Sell |
|
|||||
|
2024
Q4 | $126M | Buy |
|
|||||
|
2024
Q3 | $309M | Sell |
|
|||||
|
2024
Q2 | $211M | Buy |
|
|||||
|
2024
Q1 | $358M | Buy |
|
|||||
|
2023
Q4 | $357M | Buy |
|
|||||
|
2023
Q3 | $288M | Buy |
|
|||||
|
2023
Q2 | $313M | Buy |
|
|||||
|
2023
Q1 | $302M | Sell |
|
|||||
|
2022
Q4 | $275M | Buy |
|
|||||
|
2022
Q3 | $311M | Buy |
|
|||||
|
2022
Q2 | $241M | Buy |
|
|||||
|
2022
Q1 | $247M | Buy |
|
|||||
|
2021
Q4 | $209M | Buy |
|
|||||
|
2021
Q3 | $228M | Sell |
|
|||||
|
2021
Q2 | $156M | Buy |
|
|||||
|
2021
Q1 | $148M | Buy |
|
|||||
|
2020
Q4 | $114M | Buy |
|
|||||
|
2020
Q3 | $85.5M | Sell |
|
|||||
|
2020
Q2 | $51.2M | Buy |
|
|||||
|
2020
Q1 | $38.5M | Buy |
|
|||||
|
2019
Q4 | $62.3M | Buy |
|
|||||
|
2019
Q3 | $48.5M | Buy |
|
|||||
|
2019
Q2 | $52.2M | Buy |
|
|||||
|
2019
Q1 | $75.8M | Buy |
|
|||||
|
2018
Q4 | $119M | Buy |
|
|||||
|
2018
Q3 | $162M | Buy |
|
|||||
|
2018
Q2 | $111M | Buy |
|
|||||
|
2018
Q1 | $74.6M | Buy |
|
|||||
|
2017
Q4 | $61.7M | Buy |
|
|||||
|
2017
Q3 | $85.7M | Buy |
|
|||||
|
2017
Q2 | $95.6M | Buy |
|
|||||
|
2017
Q1 | $56.5M | Buy |
|
|||||
|
2016
Q4 | $31.7M | Buy |
|
|||||
|
2016
Q3 | $40.9M | Buy |
|
|||||
|
2016
Q2 | $19.5M | Buy |
|
|||||
|
2016
Q1 | $9.96M | Buy |
|
|||||
|
2015
Q4 | $9.6M | Buy |
|
|||||
|
2015
Q3 | $11.2M | Buy |
|
|||||
|
2015
Q2 | $1.36M | Buy |
|